UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China

• Published in: BMC pediatrics Vol. 21; no. 1; p. 259
• Main Authors: Yang, Hui, Lin, Fen, Chen, Zi-Kai, Zhang, Lin, Xu, Jia-Xin, Wu, Yong-Hao, Gu, Jing-Ying, Ma, Yu-Bin, Li, Jian-Dong, Yang, Li-Ye
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.06.2021; BioMed Central; BMC
• Subjects: Antibodies; Bilirubin; Birth weight; China; Compatibility testing (Hematology); Complications and side effects; Disease; Electronic health records; Gender; Gene mutations; Genetic aspects; Gestational age; Glucuronosyltransferase - genetics; Haplotypes; Health aspects; Hospitals; Humans; Hyperbilirubinemia; Hyperbilirubinemia, Neonatal - genetics; Infant, Newborn; Isoenzymes; Light therapy; Medical laboratories; Medical records; Mutation; Neonatal jaundice; Newborn babies; Pediatric research; Pediatrics; Polymorphism; Retrospective Studies; Serology; Uridine diphosphate; China; Asia
• ISSN: 1471-2431; 1471-2431
• DOI: 10.1186/s12887-021-02726-9

Neonatal hyperbilirubinemia causing jaundice is common in East Asian population. Uridine diphosphate glucuronosyltransferase isoenzyme (UGT1A1) glucuronidates bilirubin and converts the toxic form of bilirubin to its nontoxic form. A retrospective study was conducted to review clinical information of ABO hemolysis neonates (ABO HDN) admitted to the Department of Neonatology, referred for neonatal hyperbilirubinemia, in a large general hospital of southern China from 2011 to 2017. Variation status of UGT1A1 was determined by direct sequencing or genotype assays. Sixty-nine ABO HDNs were included into the final analysis. UGT1A1 c.211 G > A mutation (UGT1A1*6, p.Arg71Gly, rs4148323) was significantly associated with the increased bilirubin level in ABO HDNs, after adjusted by age, sex and feeding method (P = 0.019 for TBIL, P = 0.02 for IBIL). Moreover, heterozygous and/or homozygous UGT1A1 mutations in the coding sequence region were significantly associated with the increased risk of developing hazardous hyperbilirubinemia (as defined by TSB > 427 umol/L) as compared those with a normal UGT1A1 genotype (OR  = 9.16, 95%CI 1.99-42.08, P = 0.002) in the study cohort. UGT1A1 variant in coding region is actively involved in the pathogenesis of ABO hemolysis related neonatal hyperbilirubinemia. Genetic assessment of UGT1A1 may be useful for clinical diagnosis of neonatal unconjugated hyperbilirubinemia.